Empagliflozin Prescribing at MAPLE ACCESS PARTNERSHIP LLP
Drugs used in diabetes | Endocrine System
Items (12m)
1,528
Total Quantity
28.7K
NHS Cost
£35.7K
vs National Avg
+144.2%
MAPLE ACCESS PARTNERSHIP LLP prescribed 1,528 items of Empagliflozin over the last 12 months at a cost of £35,663 to the NHS. This is 144.2% above the national average prescribing rate. Empagliflozin is classified under Drugs used in diabetes in the BNF.
Monthly Prescribing Trend
Jun 2026
137
Jun 2026
116
Jun 2026
133
Jun 2026
118
Jun 2026
109
Jun 2026
136
Jun 2026
130
Jun 2026
133
Jun 2026
134
Jun 2026
130
Jun 2026
138
Jun 2026
114
Prescribing Details
| Total Items | 1,528 |
|---|---|
| Total Quantity | 28,653 |
| Total NHS Cost | £35,663 |
| Presentations | 2 different forms |
| vs National Average | +144.2% |
Empagliflozin Prescribing Comparison
| This practice | 1,528 items |
|---|---|
| National average per practice | 626 items |
| Difference | +144.2% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.